NX catalysts
Catalysts and events linked to NX, newest first.
NX stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Quanex Surges 22% After Q3 Adjusted EPS of $0.79 Tops $0.65 Consensus 2026-09-05 · Up | earnings beat pass-through to forward EPS revisions | Reported adjusted EPS of $0.79 beat consensus of $0.65 as shares climbed 22%. | Not recorded |
| Quanex Jumps 22% on Q3 Adjusted EPS of $0.79 vs $0.65 Consensus 2026-09-05 · Up | operating margin expansion lifting forward earnings power | Quanex reported Q3 EPS of $0.79 vs $0.65 expected and shares surged 22%. | Not recorded |
| Quanex Surges 22% on Q3 Adjusted EPS of $0.79 Versus $0.65 Consensus 2026-09-05 · Up | margin-driven earnings beat pass-through to equity valuation | Quanex reported adjusted EPS of $0.79 vs consensus $0.65, shares rose 22%. | Not recorded |
Do these developments change your position?
Review NX alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-09-05Quanex Surges 22% After Q3 Adjusted EPS of $0.79 Tops $0.65 ConsensusNX
- 2026-09-05Quanex Surges 22% After Q3 Adjusted EPS of $0.79 Tops $0.65 ConsensusNX
- 2026-09-05Quanex Jumps 22% on Q3 Adjusted EPS of $0.79 vs $0.65 ConsensusNX
- 2026-09-05Quanex Surges 22% on Q3 Adjusted EPS of $0.79 Versus $0.65 ConsensusNX
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.